Nucleic Acid Methylation Profiling With 5hmC Partitioning

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing nucleic acid methylation detection methods, such as bisulfite and EM-Seq, struggle to resolve the methylation status of unmethylated cytosine (C), 5-methylcytosine (5mC), and 5-hydroxymethylcytosine (5hmC) at single nucleotide resolution, leading to low sensitivity and high assay costs due to sample splitting and incomplete molecular information.

Innovation Solution

A method integrating methylation-specific base conversion with 5hmC-based partitioning into a single workflow, allowing for the resolution of unmethylated C, 5mC, and 5hmC bases on individual sequence reads by partitioning nucleic acids based on 5hmC presence, converting 5mC or unmethylated C base pairing specificity, amplifying, and sequencing to determine methylation status.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If sample splitting is used to detect different methylation statuses, then detection coverage is improved, but sensitivity decreases and assay costs increase

Engineering Contradiction:
Improvedetection coverageVSAvoidsensitivity
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent divides the detection process into two separate assays: a first assay that detects unmethylated cytosines (C) by converting them to uracil, and a second assay that detects methylated cytosines (5mC) by converting them to a different state. This segmentation allows each assay to be optimized for its specific target, improving sensitivity for each methylation status while maintaining comprehensive detection coverage through the combination of both assays.

Inventive Principle:
Principle #1Segmentation

2Measurement precision

If multiple conversion methods are used to resolve C/5mC/5hmC status, then measurement precision is improved, but device complexity increases

Engineering Contradiction:
Improvemethylation status resolutionVSAvoidassay workflow complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent segments the complex task of detecting three methylation statuses (C, 5mC, 5hmC) into two simpler, specialized assays. The first assay uses a conversion method specific for unmethylated cytosines, while the second assay uses a different conversion method for methylated cytosines. This segmentation reduces the complexity of individual assays while achieving comprehensive resolution of all methylation statuses through their combination.

Inventive Principle:
Principle #1Segmentation

3Measurement precision

If subtractive sequencing workflows are used, then measurement precision is improved, but loss of substance increases

Engineering Contradiction:
Improvemethylation pattern informationVSAvoidsample amount
Core Design Contradiction:
Measurement precisionVSLoss of substance

Solution Approach 1:

Instead of using a subtractive workflow that requires splitting and processing multiple subsamples (leading to sample loss), the patent employs two parallel conversion-based assays that can be performed on separate aliquots of the original sample. Each assay preserves molecular information by converting specific methylation statuses to detectable states, and the results are integrated to provide complete methylation pattern information without the cumulative sample loss associated with sequential subtractive processing.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables simultaneous detection of C, 5mC, and 5hmC methylation patterns on an individual molecule level, improving sensitivity and reducing costs by integrating partitioning and conversion steps into a unified process.

Implementation Method 1

subjecting the nucleic acids to a conversion procedure that selectively converts the base pairing specificity of 5-methylcytosines (5mC) or unmethylated cytosines (C) in the nucleic acids

Methodology Applied
Scientific EffectChemical conversion:

Data Source

PatentUS20260022424A1Nucleic acid methylation profiling method
Publication Date: 2026.01.22 GUARDANT HEALTH INC
  • US20260022424A1 patent drawing
  • US20260022424A1 patent drawing
  • US20260022424A1 patent drawing

AI summary

The disclosure relates to methods for determining the methylation profile of nucleic acids. The methods use base conversion methods in combination with methylation-based partitioning methods to resolve multiple types of methylation in a single workflow.